[Immunosuppressive therapy of the rheumatoid arthritis. mutual evaluation of establishments within the frame of the AFG rheumatology in jena].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005859:Germany, East; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014228:Triaziquone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D002699:Chlorambucil; D011344:Procarbazine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D014228:Triaziquone; D001379:Azathioprine; D008727:Methotrexate
Die immunsuppressive Therapie der rheumatoiden Arthritis. Gemeinschaftsauswertung von Einrichtungen im Rahmen der AFG Rheumatologic Jena